Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$8.51
-0.9%
$7.25
$6.00
$12.95
$134.09M1.2972,968 shs31,169 shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
INmune Bio, Inc. stock logo
INMB
INmune Bio
$2.61
+10.4%
$6.98
$1.89
$11.64
$55.66M1.34778,332 shs4.70 million shs
Seer, Inc. stock logo
SEER
Seer
$2.24
+1.4%
$2.05
$1.56
$2.63
$130.10M1.57280,900 shs56,239 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
-1.30%+11.90%+23.15%+29.14%+37.21%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
INmune Bio, Inc. stock logo
INMB
INmune Bio
+10.38%-58.52%-64.17%-64.17%-67.40%
Seer, Inc. stock logo
SEER
Seer
+1.40%+8.79%+4.72%+31.05%+36.65%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Well Corporation stock logo
AMWL
American Well
3.4932 of 5 stars
3.14.00.00.03.22.51.3
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
INmune Bio, Inc. stock logo
INMB
INmune Bio
1.6236 of 5 stars
3.30.00.00.02.11.70.6
Seer, Inc. stock logo
SEER
Seer
2.1728 of 5 stars
3.02.00.00.01.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Well Corporation stock logo
AMWL
American Well
2.14
Hold$9.6713.59% Upside
HEXO Corp. stock logo
HEXO
HEXO
0.00
N/AN/AN/A
INmune Bio, Inc. stock logo
INMB
INmune Bio
2.57
Moderate Buy$18.40606.33% Upside
Seer, Inc. stock logo
SEER
Seer
2.00
Hold$3.0033.87% Upside

Current Analyst Ratings Breakdown

Latest HEXO, SEER, AMWL, and INMB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
INmune Bio, Inc. stock logo
INMB
INmune Bio
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$30.00 ➝ $8.00
7/1/2025
INmune Bio, Inc. stock logo
INMB
INmune Bio
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
7/1/2025
INmune Bio, Inc. stock logo
INMB
INmune Bio
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Outperform ➝ Sector Underperform
6/30/2025
INmune Bio, Inc. stock logo
INMB
INmune Bio
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
5/23/2025
American Well Corporation stock logo
AMWL
American Well
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$10.00 ➝ $8.00
5/8/2025
American Well Corporation stock logo
AMWL
American Well
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $8.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/10/2025
American Well Corporation stock logo
AMWL
American Well
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$12.00 ➝ $7.50
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Well Corporation stock logo
AMWL
American Well
$254.36M0.52N/AN/A$20.31 per share0.42
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
INmune Bio, Inc. stock logo
INMB
INmune Bio
$10K6,142.59N/AN/A$1.45 per share1.80
Seer, Inc. stock logo
SEER
Seer
$14.17M9.31N/AN/A$5.54 per share0.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Well Corporation stock logo
AMWL
American Well
-$208.14M-$10.19N/AN/AN/A-59.13%-48.36%-35.36%7/30/2025 (Estimated)
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
INmune Bio, Inc. stock logo
INMB
INmune Bio
-$42.08M-$1.93N/AN/AN/AN/A-119.35%-89.37%7/30/2025 (Estimated)
Seer, Inc. stock logo
SEER
Seer
-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)

Latest HEXO, SEER, AMWL, and INMB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
American Well Corporation stock logo
AMWL
American Well
-$1.90N/AN/AN/A$63.87 millionN/A
5/13/2025Q1 2025
Seer, Inc. stock logo
SEER
Seer
-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million
5/8/2025Q1 2025
INmune Bio, Inc. stock logo
INMB
INmune Bio
-$0.43-$0.43N/A-$0.43N/A$0.05 million
5/1/2025Q1 2025
American Well Corporation stock logo
AMWL
American Well
-$3.09-$1.73+$1.36-$1.19$60.15 million$66.83 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Well Corporation stock logo
AMWL
American Well
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
INmune Bio, Inc. stock logo
INMB
INmune Bio
N/AN/AN/AN/AN/A
Seer, Inc. stock logo
SEER
Seer
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Well Corporation stock logo
AMWL
American Well
N/A
2.92
2.89
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
INmune Bio, Inc. stock logo
INMB
INmune Bio
N/A
2.64
2.64
Seer, Inc. stock logo
SEER
Seer
N/A
19.34
18.81

Institutional Ownership

CompanyInstitutional Ownership
American Well Corporation stock logo
AMWL
American Well
56.05%
HEXO Corp. stock logo
HEXO
HEXO
7.78%
INmune Bio, Inc. stock logo
INMB
INmune Bio
12.72%
Seer, Inc. stock logo
SEER
Seer
75.20%

Insider Ownership

CompanyInsider Ownership
American Well Corporation stock logo
AMWL
American Well
11.82%
HEXO Corp. stock logo
HEXO
HEXO
4.69%
INmune Bio, Inc. stock logo
INMB
INmune Bio
35.70%
Seer, Inc. stock logo
SEER
Seer
11.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Well Corporation stock logo
AMWL
American Well
1,04015.61 million13.77 millionOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
INmune Bio, Inc. stock logo
INMB
INmune Bio
1023.58 million15.17 millionOptionable
Seer, Inc. stock logo
SEER
Seer
16058.87 million52.23 millionOptionable

Recent News About These Companies

Seer’s brother dies in accident
U.S. Uterine Cancer Rates to Surge by 2050
D. Srihari conferred with Kempegowda Award
Here, seers are matchmakers!
Puri seer accuses Mamata of misusing religious name
Scout hall near Beaconsfield seeks licence to serve alcohol

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Well stock logo

American Well NYSE:AMWL

$8.51 -0.08 (-0.93%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$8.80 +0.29 (+3.41%)
As of 07/3/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

HEXO stock logo

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

INmune Bio stock logo

INmune Bio NASDAQ:INMB

$2.60 +0.25 (+10.38%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$2.55 -0.06 (-2.11%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers. It also provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Seer stock logo

Seer NASDAQ:SEER

$2.24 +0.03 (+1.40%)
As of 07/3/2025 01:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.